SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-158591
Filing Date
2022-05-24
Accepted
2022-05-24 16:38:03
Documents
12
Period of Report
2022-05-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d356683d8k.htm   iXBRL 8-K 26112
  Complete submission text file 0001193125-22-158591.txt   147800

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA epzm-20220520.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20220520_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20220520_pre.xml EX-101.PRE 11263
6 EXTRACTED XBRL INSTANCE DOCUMENT d356683d8k_htm.xml XML 3336
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 22957548
SIC: 2834 Pharmaceutical Preparations